845 results on '"Jacqz-Aigrain, Evelyne"'
Search Results
102. Developmental population pharmacokinetics of caffeine in Chinese premature infants with apnoea of prematurity: A post‐marketing study to support paediatric labelling in China
103. Developmental population pharmacokinetics–pharmacodynamics and dosing optimization of cefoperazone in children
104. Precision therapy of 6‐mercaptopurine in Chinese children with acute lymphoblastic leukaemia
105. Pharmacokinetics of pitolisant in children and adolescents with narcolepsy
106. Off‐label use of tacrolimus in children with glomerular disease: Effectiveness, safety and pharmacokinetics
107. Population Pharmacokinetics and Pharmacogenetics of Mycophenolic Acid Following Administration of Mycophenolate Mofetil in De Novo Pediatric Renal-Transplant Patients
108. Developmental Pharmacogenetics of SLCO2B1 on Montelukast Pharmacokinetics in Chinese Children
109. Reporting of offspring data in diabetes, HIV infection and hypertension trials during pregnancy: a systematic review
110. Population pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome
111. Characterization of a novel TPMT mutation associated with azathioprine-induced myelosuppression
112. Clinical Pharmacokinetics of Sedatives in Neonates
113. Presentation of the French Network of Paediatric Clinical Investigation Centres (CIC.P)
114. Molecular genetics of cytochrome P450 IID: Anomalies of drug metabolism
115. Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy: a report of 10 cases
116. Diclofenac and metabolite pharmacokinetics in children
117. Characteristics of prescription in 29 Level 3 Neonatal Wards over a 2-year period (2017-2018). An inventory for future research
118. Body Surface Area-Based Dosing Regimen of Caspofungin in Children: a Population Pharmacokinetics Confirmatory Study
119. Population Pharmacokinetics and Dosing Optimization of Imipenem in Children with Hematological Malignancies
120. Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infants
121. Melatonin Levels in Preterm and Term Infants and Their Mothers
122. Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Neonates and Young Infants
123. Intravesical Morphine Analgesia Is Not Effective After Bladder Surgery in Children: Results of A Randomized Double-Blind Study
124. Pharmacokinetics of the S(+) and R(−) enantiomers of vigabatrin during chronic dosing in a patient with renal failure
125. Developmental population pharmacokinetics of caffeine in Chinese premature infants with apnoea of prematurity: A post‐marketing study to support paediatric labelling in China.
126. Population pharmacokinetics and dosing optimization of azlocillin in neonates with early-onset sepsis: a real-world study.
127. Extremely low dose of 6‐mercaptopurine in a Chinese child with acute lymphoblastic leukaemia and multiple pharmacogenetic mutations.
128. 6 - Les bases de pharmacologie du développement: Pharmacocinétique et schéma posologique chez le nouveau-né
129. Assessment of individual CYP2D6 activity in extensive metabolizers with renal failure: Comparison of sparteine and dextromethorphan
130. Pharmacokinetics of ganciclovir in renal transplant children
131. Covariate effects and population pharmacokinetics of lamivudine in HIVinfected children
132. Dose-Finding Study of Omeprazole on Gastric pH in Neonates with Gastro-Esophageal Acid Reflux Using a Bayesian Sequential Approach
133. Cotrimoxazole for Prenatal Treatment of Congenital Toxoplasmosis?
134. An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial.
135. Reporting of offspring data in diabetes, HIV infection and hypertension trials during pregnancy: a systematic review.
136. Erratum to: A Novel Maturation Function for Clearance of the Cytochrome P450 3A Substrate Midazolam from Preterm Neonates to Adults
137. Population Pharmacokinetics and Dosing Optimization of Azithromycin in Children with Community-Acquired Pneumonia
138. Early target attainment of azithromycin therapy in children with lower respiratory tract infections
139. Transethnic, Genome-Wide Analysis Reveals Immune-Related Risk Alleles and Phenotypic Correlates in Pediatric Steroid-Sensitive Nephrotic Syndrome
140. Clinical trials in neonates: How to optimise informed consent and decision making? A European Delphi survey of parent representatives and clinicians
141. Aciclovir CSF concentration in children with viral encephalitis: is it adequate?
142. Population pharmacokinetics of tacrolimus in children with nephrotic syndrome
143. Pilot Study of Model-Based Dosage Individualization of Ganciclovir in Neonates and Young Infants with Congenital Cytomegalovirus Infection
144. Capacities and Competences for Drug Evaluation in European Neonatal Intensive Care Units: A Survey and Key Issues for Improvement
145. Population pharmacokinetics and dosing optimization of cefathiamidine in children with hematologic infection
146. Population Pharmacokinetics and Dosing Optimization of Ceftazidime in Infants
147. Penetration of Cefotaxime into Cerebrospinal Fluid in Neonates and Young Infants
148. Population Pharmacokinetics of Cefotaxime and Dosage Recommendations in Children with Sickle Cell Disease
149. mRNA expression of drug metabolism enzymes and transporter genes at birth using human umbilical cord blood
150. Off-label use of tacrolimus in children with Henoch-Schönlein purpura nephritis: a pilot study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.